antimicrobial resistance

Electrospinning Enables Opportunity for Green and Effective Antibacterial Coatings of Medical Devices

mycolabadmin

Scientists have developed a greener way to coat medical devices like wound dressings and catheters with antibacterial materials using electrospun fibers. These tiny fibers are made from natural, renewable materials and release antimicrobial agents slowly and effectively to prevent infections. Unlike traditional antibiotics that can create resistance, these coatings use multiple attack methods against bacteria, making them harder for microbes to develop resistance against.

Safe Meat, Smart Science: Biotechnology’s Role in Antibiotic Residue Removal

mycolabadmin

Antibiotics used to treat sick animals can leave residues in meat that contribute to dangerous antibiotic-resistant bacteria affecting human health. This review explores cutting-edge biotechnology solutions like rapid detection sensors, engineered enzymes, and bacterial viruses that can identify and eliminate these harmful residues. When combined with smarter antibiotic use on farms, these technologies offer practical ways to make meat safer and protect public health.

Winning the battle of intestinal peace with Bacillus—a multifaceted approach to animal health, immunity, and future applications in monogastric livestock production

mycolabadmin

This review examines how Bacillus bacteria, when added to animal feed, can improve the health and growth of chickens and pigs. These bacteria work by producing beneficial compounds that strengthen the gut, improve digestion, reduce harmful bacteria, and boost the immune system. Bacillus probiotics offer a natural alternative to antibiotics, helping reduce antibiotic resistance while keeping animals healthier and more productive.

Use of Ganoderma lucidum grown on agricultural waste to remove antibiotics from water

mycolabadmin

Researchers discovered that a type of mushroom called Ganoderma lucidum can help clean water contaminated with antibiotics. When the mushroom is grown on leftover agricultural materials like almond shells and coffee grounds, its root-like structure can remove certain antibiotics from water in just three days. This offers a cheap and sustainable way to address antibiotic pollution that contributes to antibiotic-resistant infections.

Green-Synthesized Nanomaterials from Edible and Medicinal Mushrooms: A Sustainable Strategy Against Antimicrobial Resistance

mycolabadmin

Scientists are developing a new weapon against antibiotic-resistant bacteria using mushrooms. These special nanoparticles derived from edible and medicinal mushrooms can kill harmful bacteria in multiple ways without the toxic chemicals used in traditional manufacturing. The nanoparticles work by disrupting bacterial membranes, creating harmful molecules called free radicals, and even boosting your body’s natural immune response. This environmentally friendly approach could become an important tool in fighting dangerous infections that don’t respond to current antibiotics.

Evaluation of Clinical, Microbiological Profiles and Management Patterns with Outcomes of Patients with Fungal Isolates in An Intensive Care Unit of A Tertiary Care Center: A Prospective Observational Study

mycolabadmin

This study examined fungal infections in critically ill patients at a major hospital, tracking 120 patients and their fungal infections. Researchers found that diabetes was the most common risk factor, with most fungal infections occurring in urine samples and commonly caused by Candida tropicalis. The study revealed that many fungal strains were resistant to common antifungal drugs like fluconazole, suggesting that doctors need to carefully choose alternative treatments based on each patient’s specific infection type.

Advancing Patient Advocacy in Mycology: Cultivating Collaboration in Education, Research, and Policy

mycolabadmin

This paper highlights how patients with fungal infections and their caregivers are rarely included in discussions about healthcare policies and research funding, unlike patients with cancer or HIV. The authors argue that fungal diseases deserve more attention and resources, and that listening to patient experiences is essential for improving how these diseases are prevented, diagnosed, and treated. They propose that dedicated advocacy organizations, like the MyCARE Foundation, can help bridge this gap and ensure fungal infections receive the policy support and research investment they need.

Lack of correlation between in vitro and within patient measures of P. aeruginosa biofilms in cystic fibrosis

mycolabadmin

Researchers compared how Pseudomonas aeruginosa bacteria form biofilms (protective clusters) in lung samples from cystic fibrosis patients versus in laboratory culture dishes. They found that the bacteria behave quite differently in the lab compared to in patients’ lungs, suggesting that laboratory tests may not accurately predict how well antibiotics will work in real patients. This highlights the importance of studying bacteria directly from patient samples to better understand how infections actually develop and progress.

Tracing the Origin and Evolution of the Fungal Mycophenolic Acid Biosynthesis Pathway

mycolabadmin

Scientists studied how different mold species produce mycophenolic acid (MPA), a drug used to prevent transplant rejection in millions of patients worldwide. By examining the genomes of nearly 500 fungal species, they discovered which molds can make MPA and how they evolved this ability. The research found that MPA-producing fungi all have special resistance mechanisms to protect themselves from the toxic compound they produce, and these protection strategies differ between species.

Prospective Study on Microbiological Profile of Fungal Isolates and its Antibiogram in a Tertiary care hospital in South India

mycolabadmin

Researchers studied fungal infections in a hospital in South India over one year, examining 62 fungal isolates. They found that Candida auris, a dangerous fungal species, was the most common and had developed resistance to many antifungal drugs. A newer class of antifungal drugs called echinocandins worked best against these infections, highlighting the importance of quick identification of fungal species for proper treatment.

Research Topic: antimicrobial resistance